Overview

Advancing Oncology Practice

The One-Day Program provides educational offerings with a concentrated focus on current oncology-related topics. These sessions are applicable to clinicians who care for patients in a variety of care settings including, acute care, outpatient and long-term care facilities, physicians’ offices, and patients’ homes. Attendees will have the opportunity to learn from clinical experts who specialize in oncology practice.

Implementing and Adhering to a Chemotherapy Exposure Management Program

9:00 - 10:00 AM PDT
  • Administration of chemotherapy expansion beyond inpatient oncology units
  • Importance of adherence to policies and procedures specific to chemotherapy exposure
  • USP General Chapter <800> standards for handling hazardous drugs in all health care settings

Benefits and Challenges in the Use of Immunotherapies for Solid Tumors

10:00 - 11:00 AM PDT
  • Outline cancer biomarkers
  • Comparing immunotherapy to chemotherapy as treatment for cancer
  • Recognition and management of immune-mediated side effects

Managing Chemotherapy Extravasation Across Transitions of Care: An Oncology CNS-driven Initiative

11:00 - 12:00 PM PDT
  • Lack of literature related to nurse management of chemotherapy extravasation beyond initial treatment
  • Significant tissue damage following extravasation
  • A formalized process for managing chemotherapy extravasations to increase patient safety and nurse satisfaction.

Hidden in Plain Sight: Strategies for Accepting and Managing Unconscious Bias

1:30 PM - 2:30 PM PDT
  • Unconscious biases by oncology providers may contribute to health disparities
  • Evidence-based strategies that center on understanding, assessing, and redirecting unconscious bias
  • Implicit bias can occur in health care settings through micro-aggressions and micro-invalidations.

Genetic Testing in Cancer Patients

2:30 PM - 3:30 PM PDT
  • Importance of genetic testing for individuals with personal or family history of susceptibility
  • Evaluation of patients for referral for genetic testing and counseling.
  • Testing results such as genetic mutations and the mechanism of carcinogenesis can aid in diagnosis and management of the disease.
Contact Hours

This entire program has been approved for 5 contact hours. Expiration date for receipt of contact hours: November 1, 2022

CRNI® Recertifications Units

This entire program has been approved for 10 CRNI® recertification units and meets the INS Meeting criteria.
*Note: Participants who attend the live version of this program at the 2019 National Academy in San Diego, CA are not eligible to receive contact hours or CRNI® recertification units through this online program.

Virtual Education

Implementing and Adhering to a Chemotherapy Exposure Management Program

Marianne Valentine, BSN, RN, CRNI®
9:00 - 10:00 AM PDT

Administration of chemotherapy has expanded well beyond inpatient oncology units. Chemotherapy is commonly administered in outpatient and long-term care facilities, physicians' offices, and patients' homes. Policies and procedures specific to chemotherapy exposure must be adhered to in order to limit the short-term and long-term consequences of exposure. USP General Chapter <800> provides standards for handling hazardous drugs in all health care settings to protect patients, caregivers, and health care personnel from potential exposure and harm.

Learning Outcomes:

After the session, attendees will: 

  1. Discuss potential toxicities of chemotherapy drugs.  
  2. List common sites where chemotherapy is administered.  
  3. Discuss USP <800> standards for hazardous drugs.  
  4. Discuss PPE, safe handling and waste disposal of chemotherapy drugs.  
  5. Discuss implications for alternate sites including and caregivers.

Benefits and Challenges in the Use of Immunotherapies for Solid Tumors

Glenda L Kaminski, PhD, MS, APRN, AOCN, CRNI®
10:00 - 11:00 AM PDT

This presentation will outline cancer biomarkers and compare immunotherapy to chemotherapy as treatment for cancer. Information about recognition and management of immune-mediated side effects related to immunotherapy, such as cutaneous, gastrointestinal, renal, respiratory, endocrine, and neurological effects will also be discussed.

Learning Outcomes:

After the session, attendees will:

  1. Recognize the differences in mechanism of action between checkpoint inhibitors and chemotherapy  
  2. Identify the most common adverse events for checkpoint inhibition in solid tumors and review the recommended management strategies  
  3. Outline the signs and symptoms that nurses need to be aware of to facilitate prompt identification and treatment of immune-related adverse events.

Managing Chemotherapy Extravasation Across Transitions of Care: An Oncology CNS-driven Initiative

Christina Colvin, MSN, APRN, AOCNS, CRNI®
Diana Karius, MS, APRN, CNS, AOCN
11:00 AM - 12:00 PM PDT

Literature related to nurse management of chemotherapy extravasation beyond initial treatment is lacking. Following extravasation, tissue damage can be significant when patients return for their regular appointment. Two oncology clinical nurse specialists designed a formal consult process to observe, manage, and make recommendations for follow-up. Since implementation of the process, multiple requests for consultations have been received. A formalized process for managing chemotherapy extravasations increases patient safety and nurse satisfaction.

Learning Outcomes:

After the session, attendees will be able to describe the necessity of a formalized process for the management of chemotherapy extravasations.


Hidden in Plain Sight: Strategies for Accepting and Managing Unconscious Bias

Paula Schultz MSN-ED, RN, CRNI®
1:30 - 2:30 PM PDT

Unconscious biases held by oncology providers may contribute to health disparities. This interactive presentation provides evidence-based strategies that center on understanding, assessing, and redirecting unconscious bias through focused debriefing, categorized management strategies, and perspective taking. Participants will learn how implicit bias can occur in health care settings through micro-aggressions and micro-invalidations.

Learning Outcomes:

After the session, attendees will: 

  1. Identify their personal level of unconscious bias awareness, its potential effect upon patient communication, and strategies for managing their perspective  
  2. Analyze effects of unconscious bias on cancer care disparities and subtle ways bias manifests in the patient/provider relationship  
  3. Compare and contrast stages of unconscious bias awareness and associated management strategies  
  4. Apply creative expression to gain insight, empathy, and relational awareness of patient situations.

Genetic Testing in Cancer Patients

Jane Lacovara, MSN, CNS-BC, CMSRN
2:30 - 3:30 PM PDT

Indications for genetic testing include individuals who have a personal or family history of genetic susceptibility. This session will discuss the importance of genetic testing in cancer treatment protocols as well as evaluate the need for referring patients for genetic testing and counseling. Attendees will also learn how the results of the testing, such as genetic mutations and the mechanism of carcinogenesis will aid in diagnosis or influence the medical or surgical management of the disease.

Learning Outcomes:

After the session, attendees will:

  1. Evaluate the need for patient referral for genetic testing and counseling 
  2. Define penetrance as it relates to genetic mutations 
  3. State the importance of genetic testing in cancer treatment protocols

Speakers

Marianne Valentine, BSN, RN, CRNI®

Nurse Manager, PharmaCare Infusion Services

Marianne Valentine, BSN, RN, CRNI®, is a Nurse Manager with PharmaCare Infusion Services. She has more than 33 years experience in infusion nursing, with 25 years in home infusion.  She is a part-time instructor at Allegany College of Maryland, teaching infusion therapy to nursing students. Marianne has been a member of  INS since 1990, and a speaker at the INS annual meeting in 2000. She was a contributing editor for Plummer’s Principles & Practice of Intravenous Therapy, 8th edition.

Glenda L Kaminski, PhD, MS, APRN, AOCN, CRNI®

Clinical Nurse Specialist, Oncology, Lakeland Regional Health

Glenda L Kaminski, PhD, MS, APRN, AOCN, CRNI®, has been a medical oncology nurse for 35 years, 25 of which were spent as a Clinical Nurse Specialist. Dr. Kaminski teaches nurses that are new to oncology about the cancer journey and how to support and educate their patients and those patients' families.

Christina Colvin, MSN, APRN, AOCNS, CRNI®

Clinical Nurse Specialist, Cleveland Clinic

Christina Colvin, MSN, APRN, AOCNS, CRNI®, began her nursing career as a clinical nurse on the adult in-patient hematology/oncology unit, expanding to include ambulatory chemotherapy infusion and hematopoietic stem cell transplant after obtaining her AOCNS in 2008.
Professional contributions include developing education, safety and support initiatives for patients and expert consultation on complex vascular access topics, including assessing extravasations, product evaluation and best practices related to general care of patients with vascular access devices.

Diana Karius, MS, APRN, CNS, AOCN

Clinical Nurse Specialist, Hematology/Oncology, Cleveland Clinic

Diana Karius, MS, APRN, CNS, AOCN is a CNS at the Cleveland Clinic  in hematology/oncology.  She has 40 years of nursing experience, with 26 of those years in Oncology. She has developed curriculum for orientation and coordinates courses in chemotherapy and End of life. Diana is a published author, and in 2011 she received the Mary Nowotny Excellence in Cancer Nursing Education award from the Oncology Nursing Society.

Paula Schultz MSN-ED, RN, CRNI®

Clinical Educator - Infusion, University Hospitals Home Care Services

Paula Schultz MSN-ED, RN, CRNI®, is Infusion Clinical Educator at University Hospitals Home Care Services, Cleveland, Ohio. With background in oncology patient and public education, Paula has presented health literacy/cultural competence training in numerous settings including the 2017 International Cancer Education Conference. She is author of Teaching Strategies to Increase Nursing Student Acceptance and Management of Unconscious Bias, and a recipient of the 2016 Jarvis Joiner Award for Clinical Excellence in Culturally Competent and Sensitive Care.

Jane Lacovara, MSN, CNS-BC, CMSRN

Clinical Nurse Specialist, University of Arizona Medical Center

Jane Lacovara is an advanced practice registered nurse and is board certified as a clinical nurse specialist and expert in oncology at the University of Arizona Medical Center in Tucson, Arizona where she provides consulting services to the high-risk cancer patients in an acute care urban hospital. In her role at the hospital, she focuses on preventing complications in solid-tumor patients for both the oncology and surgery oncology patient populations.

Already registered?
Log in to access.

Log In
Create Account

Key:

Complete
Failed
Available
Locked
Virtual Conference
Live event: 11/01/2019 at 12:00 PM (EDT) You must register to access.
Evaluation
Caring for the caregiver is often a discounted aspect of health care. Nurses pour out their compassion, strength, abilities, and expertise on behalf of their patients, yet often, their own personal health and well-being is neglected. This focus track is dedicated to building strong nurses and strong practice. This entire program has been approved for 5 contact hours and 10 CRNI® RUs and meets the INS Meeting criteria. You must register to access.
Certificate
Virtual Conference: Advancing Oncology Practice You must register to access.